• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Get Your Exam  Scores

    -or- Access your score(NABP)

    Vaccination Pharmacist

    CPR card certification must be obtained through in-person classroom instruction.


    Recent News and Updates

    ​Pharmacy Renewals​​​ started March 15, 2024. The last day to renew will be May 31,​ 2024.

    Pharmacists Professional Services

    In accordance with Senate Bill 678/House Bill 1151, the Maryland Department of Health (MDH),  will allow Medicaid-enrolled pharmacist providers to bill Maryland Medicaid for Pharmacist Professional Services (PPS) rendered within their lawful scope of practice.

    Medicaid-enrolled pharmacists can bill Maryland Medicaid using billing and coding information according to the CMS 1500 Billing Instructions at https://health.maryland.gov/mmcp/provider/Pages/ffsclaims.aspx

    To bill Fee-for-Service (FFS) Medicaid for PPS, a pharmacist must be actively enrolled with Maryland Medicaid as a participating provider type “PH" through Maryland Medicaid's online Electronic Provider Revalidation and Enrollment Portal (ePREP).

    The link to the Pharmacist Providers ePREP instructions and training for the enrollment process is https://health.maryland.gov/mmcp/provider/Pages/eprepresources.aspx. These materials are available under the "By Provider Type" heading by selecting "Pharmacist".

    Phishing Notification for PioneerRx


    RSV Update​​​

    Pursuant to Md. Code Ann., Health Occ. § 12-508(a)(3) and COMAR, a licensed pharmacist registered with the Board may administer a vaccination listed on the Center for Disease Control and Prevention’s (“CDC”) Recommended Immunization Schedule to an adult without a prescription, subject to certain requirements. On September 22, 2023, the CDC released an addendum to the Schedule adding the RSV vaccine for pregnant people during weeks 32 to 36 of gestation and adults 60 years of age and older, as recommended by ACIP and adopted by the CDC. As such, a licensed pharmacist’s vaccination administration authority for adults currently includes the RSV vaccine administered to a pregnant person during weeks 32 to 36 of gestation or to an adult 60 years of age or older.

    The Next Public Board Meeting will be held on April 17, 2024 at 9:30 AM. ​

    Th​e meeti​ng will be in person ​with a virtual option (see below)

    ​Masks will​ NOT be required.​​

    The Maryland Board of Pharmacy is currently live streaming board monthly public meetings

    Please Note:
    You will NOT get CE credits for attending virtually

    Your video, audio, and chat will be disabled and
    you will not be able to adjust these features

    To join us, use this link:


    Join before 9:30 am to ensure you are connected, attempts to connect after 9:30 will be accommodated when possible

    Comments, questions or suggestions can be emailed to

    All email will be read, but a response is not guaranteed​


    ​Medicaid Prescriber Enrollment Notice


    DEA Update

    The DEA recently published a final rule, effective July 24, 2023, which amends the regulations regarding DEA Form 106, used by registrants to formally report thefts or significant losses of controlled substances. The final rule requires that all DEA Form 106s be submitted electronically. DEA will allow registrants 45 days from discovery of the theft or significant loss to submit the form, up from the agency’s original proposal of 15 days. (In comments to the proposed rule back in September 2020, NCPA requested a 60-day timeframe, and alternately supported the proposed 15-day timeframe if that was implemented after the COVID-19 PHE ended.) Notably, the final rule does not change the requirement that registrants preliminarily notify their area DEA Field Division Office of the theft or significant loss of any controlled substances in writing within one business day of discovering such loss or theft. Paper copies of DEA Form 106 will no longer be accepted once the final rule becomes effective.

    Electronic Prescribing of Controlled Substances

    Effective January 1, 2022, Senate Bill 0166 (CH0299)/House Bill 0512 (CH0230) (2020) Drugs and Devices – Electronic Prescriptions – Controlled Dangerous Substances requires licensed health care providers to electronically prescribe prescriptions for controlled dangerous substances. The Health General Article, 21-220(C) provides exceptions to this requirement, and the requirement to request a waiver. A health care practitioner who is unable to electronically transmit prescriptions for controlled dangerous substance drugs may request a waiver from the electronic prescribing requirement under certain circumstances. A waiver, if granted, may not exceed one year.


    A pharmacist may continue to accept handwritten prescriptions. This bill allowed for a waiver and multiple exceptions. Many of the exceptions would be difficult for a pharmacist to verify. Therefore, the bill stated that a pharmacy is not required to verify the ability of a provider to issue non-electronic prescriptions. While a pharmacist does not need to verify that the prescription is an authorized exception to the electronic prescription requirement, the pharmacist must still follow due diligence requirements to ensure the prescription is written for a legitimate medical purpose.


    If you are a provider that is unable to issue controlled substance prescriptions electronically, please visit the OCSA website. On the left panel, select the “Electronic Prescribing Waiver Request". Please read the page completely to verify the need for a waiver. If you meet the criteria for one of the listed exceptions, you do not need to apply for a waiver or issue controlled substance prescriptions electronically. If you are required to apply for a waiver, click the link at the bottom of the page to submit an application for a waiver.


    ​Maryland Implicit Bias Training Requirement: Definition and Resources​​​
    ​Pursuant to MD. Code Ann., Health Occ. § 1-225, all health practitioners must attest to completing an implicit bias training program approved by the Cultural and Linguistic Health Care Professional Competency Program on their first license renewal after April 1, 2022.​​​

    Amended Governor's Orders

    2023.01.18.01 - MDH Order - Amended Various Health Care Matters Order

    2023.01.18.02 - MDH Order - Amended Nursing Home Matters Order

    Effective ​​June 30, 2021, The grace period for late fees will no longer be waived and will be due for licenses that have not been renewed when they expire after June 30, 2021. Renewals received after this period will need to be submitted as Reinstatements and will be assessed a reinstatement fee.  ​​​

    ​Previous News and Updates​

    Govern​or's Actions​

    ​Maryland Board of Pharmacy

    4201 Patterson Ave.
    Baltimore MD, 21215

    Phone: (410) 764-4755

    Email: MDH.MDBOP@maryland.gov​

    Customer Service Call Center Hours
    8:00 AM - 4:30 PM​​​

    Walk-in Hours:

    Mon-Fri. 8:30 AM-Noon

                     12:30 PM-3:30 PM​

    Holiday Schedule
    Martin Luther King Day - Jan 15

    Board of Pharmacy Office Closed


    Employee Only Site